Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.41 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34468469 | 0.93 | CYP1A2 (0.48) | CYP1A2CYP2A6LMNAOPRM1OPRD1 | |
| SCHEMBL6730322 | 0.85 | DRD2 (0.47) | CYP1A2CYP2A6LMNAOPRM1OPRD1 | |
| SCHEMBL19737304 | 0.84 | LMNA (0.47) | CYP1A2CYP2A6LMNAOPRM1OPRD1 | |
| SCHEMBL12317609 | 0.83 | OPRM1 (0.55) | LMNAOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL8395305 | 0.83 | HTR1A (0.50) | CYP1A2CYP2A6LMNAOPRM1OPRD1 | |
| SCHEMBL2778410 | 0.82 | SLC6A4 (0.54) | LMNAOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL29151340 | 0.82 | SLC6A4 (0.54) | LMNAOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL28970495 | 0.82 | SLC6A4 (0.54) | LMNAOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL21874209 | 0.82 | SLC6A4 (0.54) | LMNAOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL28970493 | 0.82 | SLC6A4 (0.54) | LMNAOPRM1OPRD1OPRK1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210122978-A1 | Liquid Crystals Comprising Cyclopentane Groups | VVI BRIGHT CHINA LTD (CN) | 2021-04-29 | — | — | US | disclosed |
| US-20210122978-A1 | Liquid Crystals Comprising Cyclopentane Groups | VVI BRIGHT CHINA LTD (CN) | 2021-04-29 | — | — | US | disclosed |
| US-10745617-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD (CN) | 2020-08-18 | — | — | US | disclosed |
| US-10745617-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD (CN) | 2020-08-18 | — | — | US | disclosed |
| US-20180163131-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2018-06-14 | — | — | US | disclosed |
| US-20180163131-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2018-06-14 | — | — | US | disclosed |
| US-9822303-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD (CN) | 2017-11-21 | — | — | US | disclosed |
| US-9822303-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD (CN) | 2017-11-21 | — | — | US | disclosed |
| US-20160237348-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2016-08-18 | — | — | US | disclosed |
| US-20160237348-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2016-08-18 | — | — | US | disclosed |
| US-20150034872-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2015-02-05 | — | — | US | disclosed |
| US-8801966-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD. (CN) | 2014-08-12 | — | — | US | disclosed |
| US-8801966-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD. (CN) | 2014-08-12 | — | — | US | disclosed |
| CN-101978024-B | Liquid crystals comprising cyclopentane groups | JINGMEISHENG OPTOELECTRIC MATERIAL NANJING CO LTD | 2014-05-07 | — | — | CN | disclosed |
| CN-103319306-A | Liquid crystals comprising cyclopentane groups | VVI BRIGHT INC | 2013-09-25 | — | — | CN | disclosed |
| CN-103320141-A | Liquid crystals comprising cyclopentane groups | VVI BRIGHT INC | 2013-09-25 | — | — | CN | disclosed |
| US-20110089374-A1 | Liquid Crystals Comprising Cyclopentane Groups | VVI BRIGHT, INC. (US) | 2011-04-21 | — | — | US | disclosed |
| US-20110089374-A1 | Liquid Crystals Comprising Cyclopentane Groups | VVI BRIGHT, INC. (US) | 2011-04-21 | — | — | US | disclosed |
| CN-101978024-A | Liquid crystals comprising cyclopentane groups | VVI BRIGHT INC | 2011-02-16 | — | — | CN | disclosed |
| WO-2009100204-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150034872-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | CXCR5, CCL5, ELOC | CYP1A2 581/4885CYP2A6 1692/4885LMNA 1247/4885 |
| US-20210122978-A1 | Liquid Crystals Comprising Cyclopentane Groups | CXCR5, CCL5, ELOC | CYP1A2 581/4885CYP2A6 1692/4885LMNA 1247/4885 |
| US-10745617-B2 | Liquid crystals comprising cyclopentane groups | CXCR5, CCL5, ELOC | CYP1A2 581/4885CYP2A6 1692/4885LMNA 1247/4885 |
| US-20180163131-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | CXCR5, CCL5, ELOC | CYP1A2 581/4885CYP2A6 1692/4885LMNA 1247/4885 |
| US-20110089374-A1 | Liquid Crystals Comprising Cyclopentane Groups | CXCR5, CCL5, ELOC | CYP1A2 581/4885CYP2A6 1692/4885LMNA 1247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.